Williams Stephen, Horrocks Iain A, Ouvrier Robert A, Gillis Jonathan, Ryan Monique M
Helen McMillan Paediatric Intensive Care Unit, The Children's Hospital at Westmead, NSW, Australia.
Pediatr Crit Care Med. 2007 Jan;8(1):18-22. doi: 10.1097/01.pcc.0000256623.01254.40.
To review the medical literature on critical illness polyneuropathy and myopathy in childhood.
Medline and EMBASE were searched using the following terms: critical illness (neuropathy, polyneuropathy, and myopathy), critical care (neuropathy, polyneuropathy, and myopathy), acute myopathy, acute necrotizing myopathy, children, and pediatric. The references listed in publications thus identified were also reviewed.
All studies relating to pediatric critical illness polyneuropathy and myopathy were included. The adult literature was also reviewed as to the current understanding of critical illness polyneuropathy and myopathy.
Critical illness polyneuropathy and critical illness myopathy are well recognized in adults, in whom they commonly cause generalized weakness and muscle wasting, with failure to wean from mechanical ventilation. Critical illness polyneuropathy and critical illness myopathy are reported in 32-100% of critically ill adult patients ventilated for >3 days. There is significant clinical and neurophysiologic overlap between the two conditions, such that the term critical illness polyneuropathy and myopathy (CIPNM) is often used. Critical illness polyneuropathy and critical illness myopathy have only occasionally been reported in childhood, and little is known of their prevalence or clinical significance in this population. This article summarizes the pediatric literature on critical illness polyneuropathy and critical illness myopathy and highlights areas for future research in critically ill children.
Critical illness polyneuropathy and myopathy may cause significant morbidity in critically ill children. These conditions seem to be clinically and electrophysiologically similar in children and adults, but prospective studies of these entities are required to better characterize their frequency, natural history, and clinical significance in pediatric practice.
回顾关于儿童危重病性多发性神经病和肌病的医学文献。
使用以下检索词在Medline和EMBASE数据库进行检索:危重病(神经病、多发性神经病、肌病)、重症监护(神经病、多发性神经病、肌病)、急性肌病、急性坏死性肌病、儿童、儿科。对由此确定的出版物中列出的参考文献也进行了回顾。
纳入所有与儿童危重病性多发性神经病和肌病相关的研究。还对成人文献中关于危重病性多发性神经病和肌病的当前认识进行了回顾。
危重病性多发性神经病和危重病性肌病在成人中已得到充分认识,它们通常导致全身无力和肌肉萎缩,并伴有机械通气脱机困难。在接受机械通气超过3天的成年危重病患者中,32% - 100%报告患有危重病性多发性神经病和危重病性肌病。这两种情况在临床和神经生理学上有显著重叠,因此常使用危重病性多发性神经病和肌病(CIPNM)这一术语。危重病性多发性神经病和危重病性肌病在儿童中仅偶尔有报道,对其在该人群中的患病率或临床意义知之甚少。本文总结了关于儿童危重病性多发性神经病和危重病性肌病的儿科文献,并强调了危重病儿童未来研究的重点领域。
危重病性多发性神经病和肌病可能在危重病儿童中导致显著的发病率。这些情况在儿童和成人中似乎在临床和电生理方面相似,但需要对这些疾病进行前瞻性研究,以更好地描述它们在儿科实践中的发生率、自然病程和临床意义。